Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Freddy A. Jimenez
4 Dec 2025
SVP & General Counsel
Sell
4,166
$29.10
$121.21K
Freddy A. Jimenez
13 Aug 2025
SVP & General Counsel
Sell
430
$25.42
$10.93K
Freddy A. Jimenez
13 Aug 2025
SVP & General Counsel
Sell
341
$23.95
$8.17K
Diane C. Young
7 Jun 2024
SVP, Chief Medical Officer
Sell
45,000
$35.26
$1.59M

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,008,121
History held since 8 Jan 2007